rdf:type |
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0033085,
umls-concept:C0178784,
umls-concept:C0205179,
umls-concept:C0205195,
umls-concept:C0278996,
umls-concept:C0439807,
umls-concept:C0542341,
umls-concept:C0684224,
umls-concept:C1517927,
umls-concept:C1522449,
umls-concept:C2827738
|
pubmed:issue |
1
|
pubmed:dateCreated |
1997-7-17
|
pubmed:abstractText |
This phase II study was performed to assess the feasibility of organ preservation after combined chemotherapy and radical radiation therapy in patients with resectable, locally advanced head and neck cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0033-8419
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
204
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
207-10
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:9205248-Adult,
pubmed-meshheading:9205248-Aged,
pubmed-meshheading:9205248-Aged, 80 and over,
pubmed-meshheading:9205248-Antimetabolites, Antineoplastic,
pubmed-meshheading:9205248-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9205248-Carcinoma, Squamous Cell,
pubmed-meshheading:9205248-Chemotherapy, Adjuvant,
pubmed-meshheading:9205248-Cisplatin,
pubmed-meshheading:9205248-Decision Trees,
pubmed-meshheading:9205248-Disease-Free Survival,
pubmed-meshheading:9205248-Feasibility Studies,
pubmed-meshheading:9205248-Female,
pubmed-meshheading:9205248-Fluorouracil,
pubmed-meshheading:9205248-Follow-Up Studies,
pubmed-meshheading:9205248-Head and Neck Neoplasms,
pubmed-meshheading:9205248-Humans,
pubmed-meshheading:9205248-Male,
pubmed-meshheading:9205248-Middle Aged,
pubmed-meshheading:9205248-Remission Induction
|
pubmed:year |
1997
|
pubmed:articleTitle |
Locally advanced head and neck cancer: combined chemotherapy and radical radiation therapy for organ and function preservation (interim report).
|
pubmed:affiliation |
Division of Radiation Oncology, Texas A&M University Health Science Center, College of Medicine, Scott and White Clinic and Memorial Hospital, Temple 76508, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|